Physician profile
Leslie Friedman
NPI 1235177445
$1,781.86
in general payments reported to CMS, 2019-2025
19 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $144 · 2021: $124 · 2022: $223 · 2023: $163 · 2024: $606 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $389.83 | 2019-2025 | Cequa |
| Alcon Vision LLC | $266.77 | 2019-2025 | Total30, Precision7 |
| Genzyme Corporation | $186.62 | 2022-2024 | |
| Johnson & Johnson Vision Care, INC. | $155.04 | 2021-2025 | Acuvue |
| Amgen INC. | $104.45 | 2024 | Tepezza |
| Bausch & Lomb Americas INC. | $99.52 | 2024-2025 | Xiidra, Miebo, Infuse |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.17 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $79.97 | 2024 | Syfovre |
| Oyster Point Pharma, INC. | $69.54 | 2022-2025 | Tyrvaya |
| Coopervision INC. | $62.52 | 2022-2024 | Myday Contact Lens |
| Allergan, INC. | $59.34 | 2019-2022 | |
| Abb Con-Cise Optical Group LLC | $46.77 | 2024 | Spectacle Lenses, Contact Lens |
| Tarsus Pharmaceuticals, INC. | $35.95 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $30.35 | 2021 | |
| Mallinckrodt Hospital Products INC. | $29.79 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $26.03 | 2019 | |
| Abbvie INC. | $25.05 | 2023 | |
| Shire North American Group INC | $14.95 | 2019 | |
| Dompe US, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.